The use of chemotherapy for the treatment of breast cancer has experienced a rapid increase in recent years and this is expected to continue. The objectives of the study were to ascertain the patient-related factors, therapy related factors, and health care system factors that influence non-adherence to chemotherapy among breast cancer survivors at University of Nigeria Teaching Hospital (UNTH), Enugu.
and predicts that there are more than 247,000 new cases of breast cancer in Nigeria by 2015 compared with about 232,000 in 2012 (2). The high incidence in developing countries like Nigeria has been attributed to scarcity of adequate facilities for detection and diagnosis (3) .
Chemotherapy (chemo) which is a systematic therapy is the treatment for breast cancer and may be given intravenously or by mouth (4) . Chemo can be used as the main treatment for women whose cancer have spread outside the breast and underarm area, either when it is diagnosed or after initial treatments. The length of treatment depends on whether the cancer shrinks, how much it shrinks, and how well the chemo is tolerated (4) . Treatment may be longer for advanced
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Breast cancer is the most common cancer in women both in developed and developing countries. It is the leading female malignancy in Nigeria and the leading cause of cancer mortality among women (1) . The peak age of breast cancer in Nigerian women is 54 years. The WHO (2016) estimates that there are 100,000 new cases of breast cancer in Nigeria. Although there is paucity of current statistics on breast cancer cases in Nigeria. Estimated 1.7 million cases were diagnosed in 2012 breast cancer and is based on how well it is working and what side effects (5) . Chemo drugs can cause side effects such as hair loss and nail changes, mouth sores, loss of appetite or increased appetite and nausea and vomiting, increased susceptibility to infection, easy bruising, depending on the type and dose of drugs given, and the length of treatment (4) .
Oncology Health Care Providers (HCPs) generally assume that patients with cancer will adhere to treatment recommendations because of the seriousness of a cancer diagnosis, however, reports in the literature have demonstrated adherence levels as low as 20% (6, 7) . Reasons for non-adherence are complex in most situations (8) . Factors that have been frequently associated with non-adherence to recommended medical therapies include individual patient characteristics, features of the disease and the treatment regimen, and aspects of the medical care system (9) . Failure to adherence of medication is a serious problem which does not only affect the patient but also the healthcare system (10). Medication non-adherence leads to substantial worsening of the disease, death and increased health cost and as such health care professionals such as nurses, doctors and pharmacist have a significant role in their daily practice to improve patient adherence to medication (2).
Nigerian health care system faces public health challenges in the form of breast cancer. The issue of non-adherence to chemotherapeutic agents among women with breast cancer has been cited by the World Health Organization (2008) as the single most important modifiable factor that can compromise treatment outcomes. Nonadherence is dangerous and can lead the practitioner to change the dose or prescribe a different agent because of apparent nonresponsiveness or unexpected adverse effects. It can also result in unnecessary diagnostic testing, changes in dose or therapeutic regimen and hospitalizations (11) . It has been observed at the University of Nigeria Teaching Hospital, Enugu that there is an increase in oncologist visit by cancer survivors due to a relapse in the disease condition. Increased hospitalization rates, longer hospital stays and decreased patient satisfaction are all possible outcomes of non-adherence to chemotherapy. This study is thus aimed at identifying factors that may impede the success of chemotherapy as these will enable Oncology health care providers to plan accurately for the treatment regimen and to improve the quality of health services provided. The specific objectives of this study are to ascertain the patient related factors, therapy related factors and health care system factors that influence non-adherence to chemotherapy among breast cancer survivors at UNTH, Enugu.
Methods
This is a cross sectional descriptive survey design study that carried out in University of Nigeria Teaching Hospital (UNTH) Enugu -Nigeria. The population for the study comprised of 100 breast cancer survivors currently receiving chemotherapy at oncology clinic of UNTH, Enugu -Nigeria. The sampling method used was census due to the small population. The entire population was used utilizing inclusion criteria of willingness of respondents to participate, and respondents on chemotherapy.
The instrument used in obtaining information for this study was the Breast Cancer questionnaire which was constructed in line with the research objectives. The Breast cancer questionnaire consisted of four sections. Section A which address the respondents' sociodemographic data and section B that determine the patient related factors that influence the non-adherence to chemotherapy among breast cancer patients at UNTH, Section C that determine the therapy related factors that influence nonadherence to chemotherapy among breast cancer patients at UNTH and section D which assess the health care system factors that influence non-adherence to chemotherapy among breast cancer patients at UNTH. Only few 21.0% were planned for while 42% were diagnosed over one year.
months ago from the time of the study respondents were diagnosed over six 
43
to participate or not without prejudice, full disclosure and maximum confidentiality of information received from respondents was maintained by removing identifying markers in the questionnaires. Table 3 shows the patient related factors that influence non-adherence to chemotherapy among breast cancer survivors at UNTH. Majority 61% were on affirmative to financial constraint, 48% worry about the outcome of treatment. Other reason given were fear of long term dependent on medication by 41%, distance from the health facility by 31%, lack of emotional support. Table 4 revealed the result of therapy related factors by the respondents. Medication side effects 62%, duration of treatment period 50%, having been told to abstain from some foods like red meat and preferring taking oral medication 43%. Table 5 reveals the healthcare related factors that affect adherence to chemotherapy, 47.0% of the respondents identified non availability of the prescribed drug in the health facility.
Results
There were also equal identification of patient-prescriber relationship and unfavorable hour of clinic visit 40.0% each and long waiting time for clinic visit by 39.0%, and non-readiness of prechemotherapy investigation results by 38.0%. 
Discussion
The study revealed that financial constraint and worry about outcome of treatment are the two major patients related factors that influences non-adherence to chemotherapy. These results might be due to the poor economic situation in Nigeria presently and the fact that breast is seen in this part of the world as an illness with no hope of survival thereby inducing worry in the respondents leading to non-adherence to chemotherapy. This study agrees with findings by Adewale, Olukayode and Adesunkanmi which reported poor economic status of the patients as one of the major reasons for non-adherence to cancer chemotherapy in Nigeria (11) . According to Anyanwu and Egwuonu (2011) , lack of health care coverage can be a barrier to seeking medical care, and probably adhering to the prescribed treatment, especially in a poor population and during hard economic times (12) . A former Nigerian health care policy allowed free-ofcharge treatment at Nigerian government hospitals to those with malignancies and other chronic ailments, and to those otherwise designated as 'teaching and research cases' in order to mitigate the burden of associated financial problem and encourage patients to seek orthodox medical care but such is no longer in existence currently. This could be a contributing factor to the financial stress experienced by patients.
The result of the study shows that majority 62(62.0%) suffered from medication side effects (hair lose, loss of weight) and duration of treatment 50(50.0%) are the major treatment factors that influences the non-adherence to chemotherapy by the participants. Drug side effects have also been given as reason for non-adherence among women taking Tamoxifen (13) . These side effects according to Schneider, Hess and Gosselin, (2013) includes alopecia, lecopenia, and pain, loss of appetite or increased appetite, increased susceptibility to infection, easy bruising, thrombocytopenia, infertility, anaemia, and dermatitis. This result agrees with Adewale, Olukayode and Adesunkanmi (11), study which reported that 11% of their study sample size was unable to further bear the drug side effects. Duration of treatment was also seen to be another therapy related factor that hinders adherence to chemotherapy; this result is in contrast with Adewale, Olukayode and Adesunkanmi study which reported that 15% of their study sample size identified fear of subsequent operation. This could be associated with the worry associated with informing patient that they would receive treatment for a long time. Another factor influencing chemotherapy non-adherence is the respondents' being told to abstain from eating some foods like meat and preference to taking drugs which might be due to the non-painful effect of taking such drug. This agrees with Kelloway, Wyatt and Adlis, (2014) (14) who identified that medications with a convenient way of administration (eg, oral medication) are likely to make patients compliant compared with injections.
The result of the study revealed that prescribed drug unavailable in the hospital pharmacy 47(47.0%) and the equal identification of patient-prescriber relationship and unfavorable hour of clinic visit 40(40%) respectively influences the respondents' adherence to chemotherapies. In the present economy, the poor budgetary allocation for 2017, meagre 4.15 per cent, though a marginal improvement on the 3.73 per cent figure of 2016 as against the WHO standard for member countries to give at least 13 per cent of its minimum allocation to the health sector if they must adequately meet the healthcare needs of their citizens. The implication of this is an under stocked pharmacy in the hospital. Also, in the area of the present study, the hospital is short staffed, this possibly resulted in designation of clinic days which may be unfavorable for patients thus the few personnel available attend to a great number of the patients on specified clinic days. This inadvertently may result in burnout on the part of the health care provider, considering the large number of patients they need to attend to, thereby creating a strain in patient-provider relationship. This is in contrast with the study of Ponnusankar (15) who discovered availability and accessibility to health care and lack of accessibility to healthcare as healthcare related factors hindering adherence to chemotherapy while Lawson et al (16) identified long waiting time for clinic visits and difficulty in getting prescriptions filled (17) , unhappy or unsatisfied clinic visits (16) which all contributed to poor compliance.
The result of the study demonstrated the various factors that influence patients' non-adherence to chemotherapy. Based on the result, financial constraint and worry about outcome of treatment, medication side effects such as hair lose, loss of weight, duration of treatment and prescribed drugs not available in the hospital pharmacy and unfavorable hour of clinic visit. This implies the nurses to design various programe such as freewill donations from church organizations and the affluent members in the society as well as the government agencies to inspire the cancer survivors in adhering to therapy. Also, health education initiation on benefit of adhering to chemotherapy would be needed on the part of the nurses to foster the women intake of chemotherapy. Nurses caring for women who receive endocrine therapy for breast cancer should identify those who may be at greater risk for being non-adherent. Therefore, nurses should assess cancer survivors to determine whether they are experiencing depression or anxiety during pre-therapy and throughout the course of therapy. Nurses also should assess women to determine whether they are experiencing symptoms related to their breast cancer or its treatment. Effective management of problems with symptoms experienced at pre-therapy and throughout therapy may help women with breast cancer maintain better adherence to endocrine therapy over time. Also, nurses need to assess whether women are experiencing financial hardships related to the cancer and its treatment and provide appropriate information and referrals so that women receive the resources they need to complete the full, prescribed course of chemotherapy. It was therefore recommended that the nurses should advocate for the patients for the federal government to re-implement the health care policy that allowed treatment free-of-charge at Nigerian Government hospitals to those with malignancies and other chronic ailments to mitigate the burden of associated financial problem and encourage patients to seek orthodox medical care. The fee for chemotherapy should also be subsidized as this would improve patient's adherence to chemotherapy. There should be cancer specific educational package with focus on knowledge about disease and treatment to be organized routinely by the health care personnel in the various health care facilities in Nigeria. More health care personnel should be made available to work in the health facility to reduce the problem of unfavorable hour of clinic visits and burnout associated with short staffing. An increase in the federal government allocation towards the health sector to reduce the problem of drug unavailability in the hospital pharmacy. The uncooperative attitude of the respondents, the small sample size which may introduce bias and limited materials on the topic.
